← Back to Search

Non-invasive Brain Stimulation

home-based active tDCS for Caregiver

N/A

Recruiting

Led By Antonio L Teixeira Jr, MD.PhD,MSc

Research Sponsored by The University of Texas Health Science Center, Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 3 years

Awards & highlights

Study Summary

This trial will assess whether it is safe to provide a certain type of electrical stimulation to Alzheimer's patients with apathy, and whether it improves symptoms.

Eligible Conditions

Caregiver of People With Alzheimer's Disease or Related Dementia (ADRD)

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

How safe home-based tDCS treatment is as measured by reporting side effects.

How satisfied the patient was with the treatment as measured by the tDCS experience questionnaire.

Number of participants included and who successfully completed the protocol.

Secondary outcome measures

Change in apathy as assessed by the Brief Dimensional Apathy Scale (b-DAS)

Change in apathy as measured by the Apathy Evaluation Scale (AES)

Change in cognition as evaluated by the Mini-Mental State Examination (MMSE)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: TreatmentExperimental Treatment1 Intervention

Group II: Control GroupPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Texas Alzheimer's Research and Care ConsortiumUNKNOWN

The University of Texas Health Science Center, HoustonLead Sponsor

903 Previous Clinical Trials

320,937 Total Patients Enrolled

Antonio L Teixeira Jr, MD.PhD,MScPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How extensive is the patient enrolment for this investigation?

"Affirmative. On clinicaltrials.gov, there is evidence that this medical trial was initially posted on August 20th 2021 and it still searching for candidates. The study needs 40 participants from a single site to be enrolled."

Answered by AI

Are there still vacancies available for those wishing to participate in this experiment?

"Affirmative. Information available on clinicaltrials.gov affirms that this medical study, first introduced on August 20th 2021, is actively looking for participants. In total 40 patients are meant to be recruited from a single site."

Answered by AI

What primary goals are being sought through the investigation of this clinical trial?

"This 6-week trial is designed to evaluate the safety of tdcs delivered at home and explore its potential effects on measures such as apathy (assessed via b-DAS), cognition (MoCA), and behavioral symptoms related to dementia (NPI). The b-DAS consists of 9 questions scored from 0 to 3, MoCA has a global score range from 0 - 30 with higher scores indicating better performance, while NPI ranges from 0 - 144 with higher numbers signifying worse outcomes."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Home-based tDCS for Apathy in Alzheimer's Disease

Antonio L. Teixeira 2021. "Home-based tDCS for Apathy in Alzheimer's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04855643.